Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana

doi:10.1016/j.preteyeres.2012.02.003

journal article May 01, 2012

Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

Stefano Barabino Yihe Chen

Sunil Chauhan

Reza Dana

Progress in Retinal and Eye Research Vol. 31 No. 3 pp. 271-285 · Elsevier BV

View at Publisher Save 10.1016/j.preteyeres.2012.02.003

Topics

No keywords indexed for this article. Browse by subject →

References

177

[1]

Abelson "Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial" Am. J. Ophthalmol. (2008) 10.1016/j.ajo.2008.01.019

[2]

Ambati "Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier" Br. J. Ophthalmol. (2007) 10.1136/bjo.2006.107417

[3]

Ambati "Corneal avascularity is due to soluble VEGF receptor-1" Nature (2006) 10.1038/nature05249

[4]

Amin "A novel mechanism of action of tetracyclines: effects on nitric oxide syntheses" Proc. Natl. Acad. Sci. USA (1996) 10.1073/pnas.93.24.14014

[5]

Aragona "Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients" Invest. Ophthalmol. Vis. Sci. (2005) 10.1167/iovs.04-1394

[6]

Barabino "Systemic linoleic and γ-linolenic acid therapy in dry eye syndrome with an inflammatory component" Cornea (2003) 10.1097/00003226-200303000-00002

[7]

Barabino "The controlled environment chamber: a new mouse model for dry eyes" Invest. Ophthalmol. Vis. Sci. (2005) 10.1167/iovs.04-1326

[8]

Barabino "Dry eye syndromes" Chem. Immunol. Allergy (2007) 10.1159/000099268

[9]

Barabino "Immune response in the conjunctival epithelium of patients with dry eye" Exp. Eye Res. (2010) 10.1016/j.exer.2010.07.008

[10]

Battat "Effects of laser in-situ keratomileusis on tear production, clearance and the ocular surface" Ophthalmology (2001) 10.1016/s0161-6420(01)00623-6

[11]

Baudouin "Preservatives in eyedrops: the good, the bad and the ugly" Prog. Ret. Eye Res. (2010) 10.1016/j.preteyeres.2010.03.001

[12]

Buchholz "Utility assessment to measure the impact of dry eye disease" Ocul. Surf. (2006) 10.1016/s1542-0124(12)70043-5

[13]

Cavet "Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells" Mol. Vis. (2010)

[14]

Chang "Tolerization of dendritic cells by T (S) cells: the crucial role of inhibitory receptors ILT3 and ILT4" Nat. Immunol. (2002) 10.1038/ni760

[15]

Chauhan "Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression" J. Immunol. (2009) 10.4049/jimmunol.182.3.1247

[16]

Chauhan "A novel pro-lymphangiogenic function for Th17/IL17" Blood (2011) 10.1182/blood-2011-01-332049

[17]

Chen "Interferon-γ-secreting NK cells promote induction of dry eye disease" J. Leukoc. Biol. (2011) 10.1189/jlb.1110611

[18]

Corcoran "Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women" J. Endocrinol. (2010) 10.1677/joe-10-0057

[19]

Correale "Role of CD8+CD25+Foxp3+ regulatory T cells in multiple sclerosis" Ann. Neurol. (2010) 10.1002/ana.21944

[20]

Cosmi "Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes" Blood (2003) 10.1182/blood-2003-04-1320

[21]

Cursiefen "Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis" Invest. Ophthalmol. Vis. Sci. (2004) 10.1167/iovs.03-0940

[22]

Cursiefen "Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision" Proc. Natl. Acad. Sci. U.S.A (2006) 10.1073/pnas.0506112103

[23]

Cursiefen "Immune privilege and angiogenic privilege of the cornea" Chem. Immunol. Allergy (2007) 10.1159/000099253

[24]

Cursiefen "Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes" J. Exp. Med. (2011) 10.1084/jem.20092277

[25]

De Paiva "Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye" Exp. Eye Res. (2006) 10.1016/j.exer.2006.02.004

[26]

De Paiva "Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline" Invest. Ophthalmol. Vis. Sci. (2006) 10.1167/iovs.05-1281

[27]

De Paiva "Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma" Invest. Ophthalmol. Vis. Sci. (2007) 10.1167/iovs.07-0069

[28]

De Paiva "IL-17 disrupts corneal barrier following desiccating stress" Mucosal. Immunol. (2009) 10.1038/mi.2009.5

[29]

Donnenfeld "Topical ophthalmic cyclosporine: pharmacology and clinical uses" Surv. Ophthalmol. (2009) 10.1016/j.survophthal.2009.02.002

[30]

Dreizen "Modulation of HLA antigen expression on corneal epithelial and stromal cells" Invest. Ophthalmol. Vis. Sci. (1988)

[31]

Dursun "Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids" Am. J. Ophthalmol. (2001) 10.1016/s0002-9394(01)00913-8

[32]

Ecoiffier "Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease" Arch. Ophthalmol. (2008) 10.1001/archopht.126.12.1695

[33]

El Annan "Characterization of effector T cells in dry eye disease" Invest. Ophthalmol. Vis. Sci. (2009) 10.1167/iovs.08-2417

[34]

El Annan "Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation" Invest. Ophthalmol. Vis. Sci. (2010) 10.1167/iovs.09-3684

[35]

Ellenberg "Novel aspects of corneal angiogenic and lymphangiogenic privilege" Prog. Retin. Eye Res. (2010) 10.1016/j.preteyeres.2010.01.002

[36]

Endarthi "CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells" J. Immunol. (2005) 10.4049/jimmunol.175.11.7093

[37]

Enríquez-de-Salamanca "Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease" Mol. Vis. (2010)

[38]

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai et al.

Journal of Experimental Medicine 2000 10.1084/jem.192.7.1027

[39]

Frucht-Pery "Efficacy of doxycycline and tetracycline in ocular rosacea" Am. J. Ophthalmol. (1993) 10.1016/s0002-9394(14)71750-7

[40]

Gao "ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice" Exp. Eye Res. (2004) 10.1016/j.exer.2003.10.024

[41]

Gayton "Etiology, prevalence, and treatment of dry eye disease" Clin. Ophthalmol. (2009) 10.2147/opth.s5555

[42]

Govek "Water-soluble PDE4 inhibitors for the treatment of dry eye" Bioorg. Med. Chem. Lett. (2010) 10.1016/j.bmcl.2010.03.023

[43]

Goyal "Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2" Arch. Ophthalmol. (2009) 10.1001/archophthalmol.2009.125

[44]

Goya "Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?" Arch. Ophthalmol. (2010) 10.1001/archophthalmol.2010.124

[45]

Goyal "Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease" Arch. Ophthalmol. (2011)

[46]

Griffith "Fas ligand-induced apoptosis as a mechanism of immune privilege" Science (1995) 10.1126/science.270.5239.1189

[47]

Guaschino "Visual function in menopause: the role of hormone replacement therapy" Menopause (2003)

[48]

Gulati "Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome" Arch. Ophthalmol. (2006) 10.1001/archopht.124.5.710

[49]

Gupta "Transforming growth factor beta-1 and beta-2 in human tear fluid" Curr. Eye Res. (1996) 10.3109/02713689609008900

[50]

Hamrah "Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells" Invest. Ophthalmol. Vis. Sci. (2002)

Showing 50 of 177 references

Cited By

275

Periostin Deletion Reduces Corneal Opacity and the Infiltration of Immune Cells

Hyemin Seong, Chieun Song · 2026

The American Journal of Pathology

Tear fluid immuno-inflammatory signatures in contact lens-induced discomfort

Archana Padmanabhan Nair, Swaminathan Sethu · 2026

Contact Lens and Anterior Eye

Current trends in pharmaceutical treatment of dry eye disease: A review

Hebatallah B. Mohamed, Basma N. Abd El-Hamid · 2022

European Journal of Pharmaceutical...

The role of Th17 immunity in chronic ocular surface disorders

Nai-Wen Fan, Thomas H. Dohlman · 2021

The Ocular Surface

The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options

Laura M. Periman, Victor L. Perez · 2020

Journal of Ocular Pharmacology and...

Review: The function of regulatory T cells at the ocular surface

William Foulsham, Anna Marmalidou · 2017

The Ocular Surface

The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome

Carlo Alberto Cutolo, Stefano Barabino · 2017

Ocular Immunology and Inflammation

Immunomodulation on the ocular surface: a review

Anna M. Ambroziak, Jerzy Szaflik · 2016

Central European Journal of Immunol...

Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients

Liangliang Niu, Shujie Zhang · 2015

PLoS ONE

The Core Mechanism of Dry Eye Disease Is Inflammation

Yi Wei, Penny A. Asbell · 2014

Eye & Contact Lens: Science &am...

Metrics

275

Citations

177

References

Details

Published: May 01, 2012
Vol/Issue: 31(3)
Pages: 271-285
License: View

Authors

Department of Ophthalmology Harvard Medical School, Schepens Eye Research Institute of Massachusetts Eye and Ear Boston Massachusetts USA

Funding

National Institutes of Health Award: EY019098

Cite This Article

Stefano Barabino, Yihe Chen, Sunil Chauhan, et al. (2012). Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease. Progress in Retinal and Eye Research, 31(3), 271-285. https://doi.org/10.1016/j.preteyeres.2012.02.003

Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

You May Also Like